VIVUS, Inc. announced the launch of an e-medicine platform that will enable patients with a prescription for Qsymia® capsules CIV to purchase the medication online and have their orders delivered directly to their homes. The online ordering platform is another component of the Qsymia Advantage Program, which is designed to improve patient access to Qsymia. With the Qsymia Advantage Program, new and existing patients with a Qsymia prescription can receive their monthly medication for $98 plus shipping and handling, a 30% or greater reduction in out of pocket expense.